Sirolimus in metatastic renal cell carcinoma

J Clin Oncol. 2008 Jul 10;26(20):3457-60. doi: 10.1200/JCO.2008.16.4590.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibiotics, Antineoplastic / administration & dosage
  • Biopsy, Needle
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / surgery
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Kidney Neoplasms / pathology*
  • Kidney Neoplasms / therapy
  • Laparoscopy / methods
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Male
  • Neoplasm Staging
  • Nephrectomy / methods
  • Palliative Care*
  • Quality of Life
  • Risk Assessment
  • Sirolimus / administration & dosage*
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus